
SignifyMD makes expert medical insights accessible and actionable for today’s oncologists and HCPs. #Oncology #Cancer #MedTwitter
Joined June 2024
- Tweets549
- Following688
- Followers179
- Likes1.4K
Pinned Tweet
Heading to #ASH26? Join the @OncBrothers and leading experts for the Advancements in Oncology (AIO) live event: an evening of discussion and networking across leukemia, myelofibrosis, lymphoma, CLL, and myeloma.
📍 New Orleans | Dec 13, 7–9:30 PM CT
Register: bit.ly/aioash26

ALT Advancements in Oncology at ASH 2026. Sunday, December 13, 7–9:30 PM CT, at 420 Julia in New Orleans. The Oncology Brothers, Rahul Gosain and Rohit Gosain, join panelists Danielle Brander, Mazyar Shadman, Matthew Lunning, Sonali Smith, Hagop Kantarjian, Raajit Rampal, Krina Patel, and S. Vincent Rajkumar for discussions on CLL, lymphoma, AML/CML/myelofibrosis, and myeloma. For healthcare providers. Register at bit.ly/aioash26.
SignifyMD retweeted
Early detection matters! 💗
I'm sharing my personal breast cancer story and how a routine screening mammogram led to an early diagnosis that made all the difference.
Watch my story and learn why early detection is so important. Get screened—it could save your life! 🎀
Breast cancer doctor faces her own diagnosis goodmorningamerica.com/video… via @GMA
SignifyMD retweeted
⭐️ Toxicity, Bridging & Shared Decision-Making in CAR T for #MultipleMyeloma
🎙️ @OncBrothers w/ @Bethfaiman , @Rfonsi1 & Carrie Bellerive, RN
👉 Broad 2L eligibility + bridging to ↓ burden/neurotox risk
👉 Early education, caregiver involvement & cross-center coordination
👉 Close CRS/ICANS monitoring + IVIG consideration
#mmsm #CART #OncTwitter #MedEd
🎥 Full discussion +summary👇
oncupdates.com/video-podcast…
SignifyMD retweeted
Replying to @OncUpdates @OncBrothers @sdent_cardioonc @hoperugo @ErikaHamilton9 @PTarantinoMD @hmcarthur @DrSAHaddad @JasmineKambojMD @HundalJasmin @drsarahsam @royaryam @SPremji7866 @RoswellPark @WilmotCancer @SignifyMD
Worth attending for the TNBC session alone. Immunotherapy combinations in that space are still evolving fast, and hearing how the panel weighs new SABCS data would be valuable. #bcsm
SignifyMD retweeted
⭐️ #ESMO26 | #HERIZON-GEA-01: OS benefit with zanidatamab regimens in 1L HER2+ mGEA
🎙️ @KlempnerSam & @ShrutiPatelMD
✅ mOS: 22.9 vs 19.6 mo (HR 0.76) zani+chemo vs tras+chemo
✅ Triplet mOS: 27 mo
#GIOnc #HER2 #OncTwitter #gism
🎥 Full discussion 👇
oncupdates.com/video-podcast…
SignifyMD retweeted
⭐️ Ep. 1: Tissue vs Liquid Biopsy Testing in HR+ mBC
🎙️ @OncBrothers + @VKaklamani @KalinskyKevin @DrWGradishar & Dr. Nazarullah discuss when and how to use tissue vs ctDNA in HR+/HER2− metastatic breast cancer.
#bcsm #BreastCancer #OncTwitter
🎥 👇
oncupdates.com/video-podcast…
SignifyMD retweeted
🤩 #HemOnc Fellows, are you going to #ASH26? Join for a FREE board review!
👀 Here is a sneak peek of your board review day!
🗓️ In-person w/@OncBrothers + @TwoOncDocs
🔗 Register: bit.ly/hemeboards
#OncTwitter #MedX #MedTwitter #ASH @HemOncFellows @hemeoncfellow
Congratulations, Dr. @Jani_Chinmay!
🏆 The most memorable moment at @FLASCO_ORG Fall 2026 was a wonderful surprise: receiving the Trailblazer Award for innovation and commitment to patients with cancer across Florida!
FLASCO has been instrumental in my training and growth as an oncologist - from supporting education and research to creating opportunities for mentorship, leadership, and collaboration. Receiving this honor from a community that has played such an important role in my journey makes it especially meaningful. 🙏
Deeply grateful to the FLASCO leadership, staff, and colleagues for their continued support. @EddieSantosMD @SylvesterCancer @HemOncMiami @GlopesMd @JTrentMDPhD @DrOlaLandgren @Latinamd @LuisRaezMD @jrgralow @ASCOTECAG @DocOncMD
Honoring the memory of Dr. @rachnatshroff , whose leadership, kindness, and commitment to advancing cancer care left a lasting impact. May her legacy continue to inspire. ❤️
support.conquer.org/p2p/site…
Dr. @rachnatshroff has dedicated her career to advancing cancer research and supporting the next generation of investigators. She is now working to permanently endow the Conquer Cancer – Rachna Shroff, MD, MS, FASCO Young Investigator Award in Biliary Cancer — creating an opportunity for that work and impact to continue for generations to come.
Please consider taking a moment to read her message, make a gift if you’re able, or simply share it with others. Every contribution and share can help bring this incredibly meaningful goal closer to reality.
SignifyMD retweeted
There is an especially outlandish conspiracy theory that oncologists are hiding the cure for cancer
Its proponents must think us particularly noble, then, when we sacrifice our lives to keep the secret: forgoing a panacea and succumbing to the very disease we treat
Dr. Shroff is not the only “wounded healer” I’ve known, but her legacy is far more than the wretched illness that claimed her own life too soon
She did her very best to push oncology forward, especially for patients with notoriously difficult-to-treat biliary tract cancers (a close relative, anatomically and sometimes pathophysiologically, to pancreatic adenocarcinoma)
I remember her incredible humility to stand at the podium at one of our largest scientific conferences and admit that a triplet therapy had not produced the benefits she had hoped for, allowing biological plausibility to cede to data yielded from the clinical trial she conceived & ran
Our field is full of such examples of good ideas failing to reach fruition, but we can only get better by admitting what’s not working as well as promoting true advances
When the history books are written, most, if not all chemo will look like grand folly, akin to our modern view of, say, blood-letting
But it is because of visionary physician-scientists like Rachna that we are making any progress at all: doing the best we can today while realizing there must be a better way and testing rigorously our ideas of how we might get there
May she be remembered in part for her tireless work, born out of irrepressible hope and true caring for her own patients as well as ones she never met (she never failed to kindly & helpfully answer a question I posed to her when I faced a management conundrum in her niche of cholangiocarcinoma)
RIP to a dear colleague (link in post below to a fund for young investigators named & bestowed in her honor)
We join the oncology community in mourning the passing of Dr. Rachna T. Shroff, a renowned GI cancers expert and a dedicated ASCO volunteer. We are humbled by her dedication and strive to honor her legacy of commitment and altruism.
Read more: bit.ly/4e7jBKu
SignifyMD retweeted
Next few months are going to be busy! #SABCS26 -> #ASH26 -> #GI27 ->#GU27
During #GI27 we will get a chance to touch on the data in person. We would love to see you there!
In Person Jan 22, 2027 w/ @YJanjigianMD @DrShubhamPant @NVijayvergiaMD @MDmanishshah @smitha42
Register bit.ly/aiogi27
#OncTwitter #gism
Congrats, Dr. @TiansterZhang!
So well deserved @TiansterZhang! Fortunate to have you as a colleague and even more fortunate to have you as a friend. Keep up the tremendous work! @KidneyCancer @utswcancer @kidneycan
SignifyMD retweeted
Comprehensive review article by Sara Hurvitz @fredhutch on state of the art advances in MBC treatment, published in @NEJM. This is also a timely reference for MDs and scientists and to cite in papers, grants, presentations. @SusanGKomen @BCRFcure @ASCO @AACR @PIK3CApathbreak
nejm.org/doi/full/10.1056/NE…
SignifyMD retweeted
Excited to report that FDA has approved atezolizumab + FP and oxali as adjuvant therapy for stage 3 dMMR colon cancer. Important advance for patients worldwide. @FASinicropeMD @MayoCancerCare @MayoClinic @ASCO @AACR @ASCOPost @myESMO @ALLIANCE_org
FDA approves new treatment option, #atezolizumab in combination with chemotherapy, for patients with stage III dMMR #coloncancer based on results from the phase III #ATOMIC trial led by @ALLIANCE_org. Learn more: bit.ly/FDA-ATOMIC @theNCI #NCTN #CancerResearch #CRCsm
SignifyMD retweeted
Atezolizumab is now @FDA ✅ off #ATOMIC Ph III, adj mFOLFOX + Atezo vs. mFOLFOX in Stg III dMMR colon ca.
- 3yr DFS 86.4% vs 76.6% (HR 0.50)
- OS not mature
- ⬆️ Gr4 neutropenia with Atezo.
- How much is chemo benefitting? Role of NICHE2?
- @ASCO Plenary!
#gism #OncTwitter
SignifyMD retweeted
⭐️ #EXCALIBER-RRMM: Iberdomide + Dara + Dex in RRMM
✅ mPFS 42 vs 20 mo with DVd
👉 Confirmatory PFS for the MRD-based approval
⚠️ Neutropenia, infections, VTE
#mmsm #MultipleMyeloma #OncTwitter #HemOnc #OncUpdates #MedTwitter #MedX
🔗Full Summary 👇
oncupdates.com/article/iberd…
SignifyMD retweeted
In Small Cell Lung Cancer “Challenging Case” discussion with @Latinamd & @drshieldsmd:
✅ Limited & Extensive Stg
✅ MAVERICK data
✅ Supportive care
✅ Maintenance & Sequencing
Full 🗣️:
⭐️ oncbrothers.com/cc-sclc-2026
⭐️ “Oncology Brothers” podcast
#OncTwitter @OncoAlert
SignifyMD retweeted
From appreciating broader treatment landscape to acknowledging regional differences, #EOS2026 @SocietyEmirates was a great learning experience. Our personal highlights!
#OncTwitter
SignifyMD retweeted
Today’s approval makes 11 in #breastcancer since May 1! Google “FDA oncology approvals” for searchable list of heme/oncology FDA approvals (2006 to now) w/ a concise description of each, in reverse chronological order. A+ for Boards prep or clinical practice. #OncTwitter #bcsm
Pretty stunning review on advances in breast cancer treatment in this week’s NEJM
So many new approvals since 2020 that they could only fit on a 2-page centerfold!!!
Looks like it’s the roaring 20s in breast cancer research!
#bcsm
SignifyMD retweeted
🤔Going to #SABCS26?
📍Join Us for the @OncBrothers #AIO event!
🗓️In Person Dec 9th,2026
⭐️Faculty Panel @sdent_cardioonc @hoperugo @ErikaHamilton9 @PTarantinoMD @hmcarthur + DrSaraHurvitz
🔗Register: bit.ly/aiosabcs26
#bcsm #OncTwitter #BreastCancer @SABCSSanAntonio





























